Suchergebnisse - "van Mulligen, Elise"

PubPharm (12)

1

Tapering conventional synthetic DMARDs towards sustained drug-free remission in rheumatoid arthritis

enthalten in: The Lancet. Rheumatology | 2024

von van Mulligen, E.

2

Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis : a validation study

enthalten in: Annals of the rheumatic diseases | 2023

von van Mulligen, E. | van der Helm-van Mil, A. | de Jong, P.

CommentOn: Ann Rheum Dis. 2020 Nov;79(11):1516-1517. - PMID 32467248

3

Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis

enthalten in: Expert review of clinical immunology | 2023

von D'Onofrio, B. | van der Helm-van Mil, A. | W J Huizinga, T. | +1

4

Response to : 'Correspondence on 'Tapering towards DMARD-free remission in rheumatoid arthritis' by Garcia et al

enthalten in: Annals of the rheumatic diseases | 2023

von van Mulligen, E. | de Jong, P.

CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1174-1181. - PMID 32482645

5

Response to : 'Tapering antirheumatic drugs in a resource-poor setting: real-world evidence' by Haroon et al

enthalten in: Annals of the rheumatic diseases | 2022

von van Mulligen, E. | de Jong, P.

CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1174-1181. - PMID 32482645

6

Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patients

enthalten in: Rheumatology (Oxford, England) | 2022

von Looijen, A. | van Mulligen, E. | van der Helm-van Mil, A. | +1

7

Work participation is reduced during the development of RA, months before clinical arthritis manifests

enthalten in: Rheumatology (Oxford, England) | 2022

von Rogier, C. | de Jong, P. | van der Helm-van Mil, A. | +1

8

Factors that influence biological survival in rheumatoid arthritis : results of a real-world academic cohort from the Netherlands

enthalten in: Clinical rheumatology | 2021

von van Mulligen, E. | Ahmed, S. | Weel, A. | +3

9

Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis : cost-utility analysis of the TARA trial

enthalten in: Annals of the rheumatic diseases | 2020

von van Mulligen, E. | Weel, A. | Kuijper, T. | +8

10

Tapering towards DMARD-free remission in established rheumatoid arthritis : 2-year results of the TARA trial

enthalten in: Annals of the rheumatic diseases | 2020

von van Mulligen, E. | Weel, A. | Hazes, J. | +2

CommentIn: Ann Rheum Dis. 2022 Oct;81(10):e208. - PMID 32816707